To compare three different doses of dexmedetomidine in patients undergoing awake fibreoptic intubatio
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/11/037832
- Lead Sponsor
- DY Patil Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1All patient giving consent
2Patient undergoing elective oro-maxillo-facial and oral malignancy surgeries
3Patients >18 years or <60 years
4Patients of either sex
5ASA grade I and II
Exclusion Criteria
1Patients not consenting
2Patient with coagulopathies or on anticoagulants
3Nasal mass or Adenoids
4Patients with severe renal, hepatic, respiratory or cardiac diseases, infection at the site of the block, pregnancy and neuromuscular disorders
5Patients with any known allergy to dexmedetomidine
6Patients with any contraindication to dexmedetomidine
7Lack of cooperation or effective communication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare between three different doses of dexmedetomidine for sedation on intubation condition in awake nasotracheal fiberoptic intubation. <br/ ><br>The primary objective is to compare between three groups: Intubation score, patientsâ?? tolerance, 3-point assessment score immediately after nasotracheal intubation, hemodynamic parameters and incidence of oxygen desaturation if any. <br/ ><br>Timepoint: To compare pre infusion, 5 mins after infusion, 10 mins after infusion, pre intubation, during intubation and post intubation
- Secondary Outcome Measures
Name Time Method Secondary objective is to observe side effects of drug, if anyTimepoint: 1.5 years